News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|October 25, 2017

Understanding Targeted Therapies

Newsletter

Stay up to date on cancer updates, research and education

Related Content

$The FDA approved Breyanzi for adults with relapsed or refractory marginal zone lymphoma who received at least two prior lines of systemic therapy: © stock.adobe.com.$

FDA Approves Breyanzi in Relapsed/Refractory Marginal Zone Lymphoma

December 4th 2025

Martha Carlson received a diagnosis of metastatic breast cancer in 2015. Read all of Martha's blogs here!

11 Years Living With Stage 4 Cancer Inspires Gratitude and Reflection

ByMartha Carlson

December 4th 2025

myelofibrosis

An Educational Overview of Newly Diagnosed Stage 1 Myelofibrosis

December 4th 2025

As part of her journey with stage 3 inflammatory breast cancer, Lindsey Gunter experienced chemotherapy side effects so severe that she was unable to walk.

Chemo Side Effects for Breast Cancer Led to Weeks in the Hospital

December 4th 2025

Mary Sansone

Advice From a Cancer Survivor: Keep Your Appointments!

December 4th 2025

Trending on CURE

Every FDA Oncology Approval From November 2025

Finding Support When People Say Others Have It Worse

Reflecting on My Sister’s Final Days After Years of Unexpected Rebounds

What Fatigue Feels Like for a Patient With Polycythemia Vera

Breaking Down Treatment Advancements for Small Cell Lung Cancer

© 2025 MJH Life Sciences^®

All rights reserved.